The UK financial markets saw some movements during the last week, with the FTSE rising by 10 points to close at 5,924 and the AIM All Share closing at the same level of 688. News has included UK consumer price inflation remaining unchanged at 2.7 per cent in November and UK house prices rising 0.2 per cent on October, whilst the US saw a 0.3 per cent fall in its consumer price index. Discussions on the US ‘Fiscal Cliff’ were also said to be progressing, with a deal required by 1st January to avoid the implementation of steep tax rises and sharp spending cuts. The week ahead sees the Bank of England Monetary Policy Committee minutes to rates meeting, UK public finance data and US third quarter GDP results all being announced. If you would like to unsubscribe, please email enquiries@hybridan.com with “unsubscribe me”. Disclaimer- This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only- please refer to the disclaimer in full below.  

  Angle (LON:AGL 25.5p/£10.28m) ANGLE, the specialist medtech company, this morning announced that it has released its Parsortix non-invasive cancer diagnostic product to its research partners. ANGLE’s patent-protected Parsortix technology enables the simple and effective capture and counting of very rare circulating tumour cells from cancer patient blood. ANGLE has established long term partnership arrangements with two research partners: the Cancer Research UK-funded Paterson Institute for Cancer Research, The University of Manchester’s world-leading cancer research institute; and the University of Surrey’s Oncology Department, which works alongside the Royal Surrey Hospital and is a leading UK cancer research centre. The main areas of focus for the first stage of the research partners’ work will include further development of the staining / cell identification protocols to mark the captured cells definitively as cancer cells in the GEN3 cassette; and testing of the system with cancer patient blood to provide independent confirmation of the performance of the Parsortix device. Following confirmation from these research partners that the system is working successfully, ANGLE expects to be able to release a product for research purposes for sale early in the New Year.

Anglo Asian (LON:AAZ 48p/£53.5m) Anglo Asian Mining, a gold producer with a broad portfolio of production and exploration assets in Azerbaijan, has signed a contract with Glencore for the sale of 2,500 wet tonnes and 550 dry tonnes of copper…

Unlock the rest of this article with a 14 day trial

or Unlock with your email

Already have an account?
Login here